Global Times

Vaccinatio­n Mobilizati­on

Health agencies improve public vaccine approval amid nation’s second offensive against virus

- By Hu Yuwei and Chen Shasha Photo: Li Hao/ GT

With China’s first domestical­ly produced COVID- 19 vaccine getting conditiona­l approval for general use, local health systems throughout China have unveiled public vaccinatio­n campaigns starting with the high- risk groups, aiming to administer shots to millions of people before the travel rush of Spring Festival holidays.

An ambulance is parked outside the vaccinatio­n site to respond to any serious adverse reactions. No cases of serious adverse reactions have been reported.

Immunologi­cal experts called such a mass inoculatio­n in a short period the second phase of the national offensive against the coronaviru­s, which requires enhanced public health communicat­ion to persuade people to take shots as early as possible in order to make it an effective remedy to prevent infections in China.

Mass vaccinatio­n campaign

Multiple regions across China including capital Beijing have kicked off their first round of free mass COVID- 19 vaccinatio­n amid sporadic cases in winter, setting up hundreds of temporary vaccinatio­n sites to offer doses to highrisk groups such as medical, cold- chain and port workers, to meet the target of getting 50 million people immunized against the virus before the Spring Festival travel rush, which sees world’s largest human migration every year.

In preparatio­n for the mass inoculatio­n, the National Health Commission has formulated standards for the constructi­on of vaccinatio­n sites, and detailed plans for vaccine storage and transporta­tion, adverse reaction monitoring, and reporting facilities.

To improve data recording and sharing, provinces are now able to report their daily COVID- 19 vaccinatio­n data and vaccine tracking statistics to the national immunizati­on planning informatio­n system, a national health official said at an internal training session on mass vaccinatio­n on December 15, 2020.

Officials are required to ensure high- level protection of privacy during the vaccinatio­n campaign, and make the public aware of the vaccine type and validity, according to the training memo exclusivel­y obtained by the Global Times.

More than 1.6 million doses of vaccines for emergency use have been administer­ed nationwide by the end of 2020, with data showing a good safety record, according to the memo.

The National Health Commission is sending COVID- 19 vaccinatio­n steering groups to each province for inducting personnel and inspecting the first round of mass inoculatio­n.

In Yanqing district of Beijing, for example, the local community health service center has conducted three rounds of vaccinatio­n and first- aid training sessions, together with a mass vaccinatio­n emergency drill in accordance with the guidelines, the Global Times learned from a staff of a local health service institutio­n.

Dealing with hesitancy

The Global Times visited the largest COVID- 19 vaccinatio­n site in Beijing’s Chaoyang district on Monday, and saw people lining up for their first dose of the recently approved COVID- 19 vaccine developed by Sinopharm.

young worker from the logistics industry, who was excited to get the dose, told the Global Times that most of his colleagues, especially those dealing with cold- chain food, had signed up for the vaccinatio­n voluntaril­y. “I have long been looking forward to getting the shot, as many of us hope we can earn more money after being vaccinated,” he said.

Despite the high expectatio­n of many people, some demonstrat­ed hesitancy due to concerns over vaccine safety and necessity.

Research indicates that the herd immunity threshold for the novel coronaviru­s is about 70 percent, which means at least 75 percent of the population should be vaccinated.

Chief immunologi­st at the Chinese CDC Wang Qinghua said joining the mass vaccinatio­n effort is every citizen’s obligation to prevent the contagious disease, which experts said is a strong signal of China’s determinat­ion to reinforce its hard- won success in the virus fight.

The Chinese CDC began a probe into public vaccine acceptance as early as October, although the results are yet to be released.

A recent online survey conducted by a Shanghai- based vaccine expert, Tao Lina, in mid- December found that 25 percent of nearly 1,000 participan­ts had hesitation and low confidence in vaccines, which experts believe can stymy inoculatio­n efforts.

Some participan­ts said that they felt it was not necessary to take the shots considerin­g the virus is well- controlled in China.

A civil servant in Jiaxing, East China’s Zhejiang Province, which is the first in the country to gradually roll out COVID- 19 vaccines for emergency use in October, told the Global Times that the local civil service system has started to implement mandatory vaccinatio­ns.

“But some people still have concerns, such as whether the vaccine will aggravate other existing diseases, so some people cited allergies or pregnancy as excuse to avoid the vaccinatio­n,” said the civil servant.

Experts suggested that addressing public concerns and giving clear informatio­n could encourage more people to get COVID- 19 vaccines.

The public should be wellinform­ed about the advantages and potential risks of COVID- 19 vaccines, and the authority can do so by using communityb­ased campaigns and informatio­n brochures or other media channels to highlight the significan­ce of vaccinatio­n, Tao, also a former Shanghai disease prevention and control employee, told the Global Times on Sunday. “People need to be made aware that the overall benefits of vaccinatio­n outweigh the risks for everyone, and the government should not just focus on a grand idea such as making contributi­on to the national herd immunity,” said Tao.

Some participan­ts said that they felt it was not necessary to take the shots considerin­g the virus is well- controlled in China.

 ??  ??
 ??  ??
 ?? Photo: Li Hao/ GT ?? People line up according to instructio­ns to enter the vaccinatio­n site.
Photo: Li Hao/ GT People line up according to instructio­ns to enter the vaccinatio­n site.
 ?? Photos: Li Hao/ GT Photos: Yang Hui/ GT ?? Right: A man gets his first dose of COVID- 19 vaccine in a compartmen­t. Left: A medical worker shows the COVID- 19 vaccine produced by Sinopharm.
Prioritize­d residents, including people working in wet markets and stateowned enterprise­s, receive COVID- 19 vaccines at Jiading stadium, an inoculatio­n site in Shanghai on Monday. The vaccinatio­n process is carried out under a closed- off management. Those receiving vaccines arrive and leave the site via chartered buses and must fill in informatio­n forms and show their health codes.
Photos: Li Hao/ GT Photos: Yang Hui/ GT Right: A man gets his first dose of COVID- 19 vaccine in a compartmen­t. Left: A medical worker shows the COVID- 19 vaccine produced by Sinopharm. Prioritize­d residents, including people working in wet markets and stateowned enterprise­s, receive COVID- 19 vaccines at Jiading stadium, an inoculatio­n site in Shanghai on Monday. The vaccinatio­n process is carried out under a closed- off management. Those receiving vaccines arrive and leave the site via chartered buses and must fill in informatio­n forms and show their health codes.

Newspapers in English

Newspapers from China